Myocardite et maladie à COVID-19 : où en est-on ?

The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fard, D., Huguet, R., Koutsoukis, A., Deguillard, C., Tuffreau, A.-S., Deux, J.-F., Lim, P., Teiger, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Mise Au Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543970/
https://www.ncbi.nlm.nih.gov/pubmed/33069383
http://dx.doi.org/10.1016/j.ancard.2020.10.001
_version_ 1783591764277329920
author Fard, D.
Huguet, R.
Koutsoukis, A.
Deguillard, C.
Tuffreau, A.-S.
Deux, J.-F.
Lim, P.
Teiger, E.
author_facet Fard, D.
Huguet, R.
Koutsoukis, A.
Deguillard, C.
Tuffreau, A.-S.
Deux, J.-F.
Lim, P.
Teiger, E.
author_sort Fard, D.
collection PubMed
description The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsible for multiple organ damage, of which cardiac injury seems to be the most represented. This cardiac injury can present as acute myocarditis. Our aim was to discuss the pathophysiological rationale underlying the existence of SARS-CoV-2 myocarditis and to analyze the literature data regarding the diagnosis and treatment of this particular entity.
format Online
Article
Text
id pubmed-7543970
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-75439702020-10-09 Myocardite et maladie à COVID-19 : où en est-on ? Fard, D. Huguet, R. Koutsoukis, A. Deguillard, C. Tuffreau, A.-S. Deux, J.-F. Lim, P. Teiger, E. Ann Cardiol Angeiol (Paris) Mise Au Point The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsible for multiple organ damage, of which cardiac injury seems to be the most represented. This cardiac injury can present as acute myocarditis. Our aim was to discuss the pathophysiological rationale underlying the existence of SARS-CoV-2 myocarditis and to analyze the literature data regarding the diagnosis and treatment of this particular entity. Elsevier Masson SAS. 2020-12 2020-10-08 /pmc/articles/PMC7543970/ /pubmed/33069383 http://dx.doi.org/10.1016/j.ancard.2020.10.001 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Mise Au Point
Fard, D.
Huguet, R.
Koutsoukis, A.
Deguillard, C.
Tuffreau, A.-S.
Deux, J.-F.
Lim, P.
Teiger, E.
Myocardite et maladie à COVID-19 : où en est-on ?
title Myocardite et maladie à COVID-19 : où en est-on ?
title_full Myocardite et maladie à COVID-19 : où en est-on ?
title_fullStr Myocardite et maladie à COVID-19 : où en est-on ?
title_full_unstemmed Myocardite et maladie à COVID-19 : où en est-on ?
title_short Myocardite et maladie à COVID-19 : où en est-on ?
title_sort myocardite et maladie à covid-19 : où en est-on ?
topic Mise Au Point
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543970/
https://www.ncbi.nlm.nih.gov/pubmed/33069383
http://dx.doi.org/10.1016/j.ancard.2020.10.001
work_keys_str_mv AT fardd myocarditeetmaladieacovid19oueneston
AT huguetr myocarditeetmaladieacovid19oueneston
AT koutsoukisa myocarditeetmaladieacovid19oueneston
AT deguillardc myocarditeetmaladieacovid19oueneston
AT tuffreauas myocarditeetmaladieacovid19oueneston
AT deuxjf myocarditeetmaladieacovid19oueneston
AT limp myocarditeetmaladieacovid19oueneston
AT teigere myocarditeetmaladieacovid19oueneston

Ejemplares similares